Skip to content

A Retrospective Cohort Study on the Prognosis of Plasma Transfusion in the Treatment of Postpartum Hemorrhage

A Retrospective Cohort Study on the Prognosis of Plasma Transfusion in the Treatment of Postpartum Hemorrhage

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500115542
Enrollment
Unknown
Registered
2025-12-29
Start date
2025-12-29
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum Hemorrhage

Interventions

Observation group:None

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1.Hospitalized postpartum women; 2. 18-40y; 3.Diagnosed as postpartum hemorrhage; 4.Complies with transfusion indications; 5.Postpartum transfusion of>=1U red blood cells within 6h.

Exclusion criteria

Exclusion criteria: 1.Postpartum women hospitalized; 2.Hospitalized abortion and induced abortion mothers; 3.Prenatal infusion or 24 hours after delivery; 4.Incomplete information.

Design outcomes

Primary

MeasureTime frame
Persistent bleeding;Maternal death;Hysterectomy;Arterial embolization;

Secondary

MeasureTime frame
Fever;Allergy;Thrombosis;Infection;Infusion of other blood products (red blood cells, platelets, cryoprecipitate);Length of hospital stay;ICU transfer rate;Massive blood transfusion initiation;The largest APTT;The largest Hb;The largest Fib;The largest INR;

Countries

China

Contacts

Public ContactChen Shaoheng

Shanghai General Hospital

chenshaoheng@sjtu.edu.cn+86 135 2474 6568

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026